Literature DB >> 2166808

Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus.

H Brüssow1, P A Offit, G Gerna, A Bruttin, J Sidoti.   

Abstract

Reassortants between serotype 3 SA11 and serotype 6 NCDV rotaviruses were used to determine the relative amounts of serum-neutralizing antibody to VP4 and VP7 of serotype 3 SA11 rotavirus in children after natural rotavirus exposure. Sera from Ecuadorian children of a population-based study and sera from children of a hospital-based study in Germany (excluding diarrhea patients) demonstrated high titers of VP7-specific but only low titers of VP4-specific antibodies. In contrast, paired sera from German children hospitalized with a symptomatic primary rotavirus gastroenteritis demonstrated a titer increase to VP4 more frequently than to VP7 protein by neutralization test and immunoblotting. For these rotavirus patients, we provided, previously, direct evidence for the development of cross-neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166808      PMCID: PMC247876          DOI: 10.1128/JVI.64.9.4130-4136.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  A candidate for a new serotype of human rotavirus.

Authors:  S Matsuno; A Hasegawa; A Mukoyama; S Inouye
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

2.  Rotavirus VP7 neutralization epitopes of serotype 3 strains.

Authors:  K Nishikawa; Y Hoshino; K Taniguchi; K Y Green; H B Greenberg; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

3.  Serotype determination of human rotavirus isolates and antibody prevalence in pediatric population in Hokkaido, Japan.

Authors:  S Urasawa; T Urasawa; K Taniguchi; S Chiba
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens.

Authors:  A R Kalica; H B Greenberg; R G Wyatt; J Flores; M M Sereno; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

5.  Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes.

Authors:  R G Wyatt; H D James; A L Pittman; Y Hoshino; H B Greenberg; A R Kalica; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

6.  Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus.

Authors:  H B Greenberg; J Flores; A R Kalica; R G Wyatt; R Jones
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

7.  Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes.

Authors:  K Y Green; Y Hoshino; N Ikegami
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Serotyping of cell culture-adapted subgroup 2 human rotavirus strains by neutralization.

Authors:  G Gerna; M Battaglia; G Milenesi; N Passarani; E Percivalle; E Cattaneo
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; J Flores; A Z Kapikian
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

View more
  11 in total

1.  Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children.

Authors:  H Brüssow; P A Offit; J Sidoti
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women.

Authors:  H Brüssow; J Sidoti; L Lerner; H Rahim; W Eckstein; H Werchau; C Mietens
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

3.  Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope.

Authors:  C Delorme; H Brüssow; J Sidoti; N Roche; K A Karlsson; J R Neeser; S Teneberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice.

Authors:  S Ishida; N Feng; B Tang; J M Gilbert; H B Greenberg
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  VP4-specific intestinal antibody response to rotavirus in a murine model of heterotypic infection.

Authors:  R D Shaw; W S Groene; E R Mackow; A A Merchant; E H Cheng
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Prevalence of serum neutralizing antibody to serotype 9 rotavirus WI61 in children from South America and central Europe.

Authors:  H Brüssow; H F Clark; J Sidoti
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

7.  Isolation and characterization of two distinct human rotavirus strains with G6 specificity.

Authors:  G Gerna; A Sarasini; M Parea; S Arista; P Miranda; H Brüssow; Y Hoshino; J Flores
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

8.  Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.

Authors:  Carl D Kirkwood; Karen Boniface; Simone Richardson; Zenobia F Taraporewala; John T Patton; Ruth F Bishop
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

9.  Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.

Authors:  L Padilla-Noriega; L Fiore; M B Rennels; G A Losonsky; E R Mackow; H B Greenberg
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

10.  Neutralizing serum antibodies to serotype 6 human rotaviruses PA151 and PA169 in Ecuadorian and German children.

Authors:  H Brüssow; G Gerna; J Sidoti; A Sarasini
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.